Showing results (101-110 of 139) with videos related to

Sort By:
Pageof 14
Physical Review Letters|December 1, 2020
Mixed-State Entanglement from Local Randomized MeasurementsAndreas Elben, Richard Kueng, Hsin-Yuan Robert Huang, et al.
Multiple Sclerosis and Related Disorders|December 5, 2022
Engagement in volunteering activities by persons with multiple sclerosis in SwitzerlandMathias Mettler, Mina Stanikić, Urban Schwegler, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2013
The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patientsÖzgür Yaldizli, Iris-Katharina Penner, Karl Frontzek, et al.
Swiss Medical Weekly|May 17, 2018
A digitally facilitated citizen-science driven approach accelerates participant recruitment and increases study population diversityMilo A Puhan, Nina Steinemann, Christian P Kamm, et al.
Physical Review Letters|July 23, 2024
Observing the Quantum Mpemba Effect in Quantum SimulationsLata Kh Joshi, Johannes Franke, Aniket Rath, et al.
Annals of Clinical and Translational Neurology|October 8, 2020
Levels of brain-derived neurotrophic factor in patients with multiple sclerosisYvonne Naegelin, Katharina Saeuberli, Sabine Schaedelin, et al.
Disability and Rehabilitation|December 16, 2022
Digitally Assisted Standard Diagnostics in Insurance Medicine (DASDIM): psychometric data in psychiatric work disability evaluationsTimm Rosburg, Gunnar Deuring, Gerhard Ebner, et al.
Plos One|November 21, 2024
Factors associated with low health-related quality of life in persons with multiple sclerosis: A quantile-based segmentation approachStefania Iaquinto, Benjamin Victor Ineichen, Anke Salmen, et al.
Multiple Sclerosis and Related Disorders|July 31, 2018
The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?Laura Barin, Anke Salmen, Giulio Disanto, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 19, 2018
Factors associated with time from first-symptoms to diagnosis and treatment initiation of Multiple Sclerosis in SwitzerlandMarco Kaufmann, Jens Kuhle, Milo A Puhan, et al.
Pageof 14